metricas
covid
Buscar en
Revista Colombiana de Reumatología
Toda la web
Inicio Revista Colombiana de Reumatología Síndrome pulmón-riñón en lupus severo asociado a ANCA: ¿un síndrome de sob...
Información de la revista
Vol. 20. Núm. 1.
Páginas 64-71 (marzo 2013)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 20. Núm. 1.
Páginas 64-71 (marzo 2013)
Acceso a texto completo
Síndrome pulmón-riñón en lupus severo asociado a ANCA: ¿un síndrome de sobreposición?
Lung - kidney syndrome in severe lupus ANCA associated: overlap syndrome?
Visitas
4870
Nasser Abdel Polanco Flores1,
Autor para correspondencia
, María Virgilia Soto Abraham2, Francisco Eugenio Rodríguez Castellanos1
1 Servicio de Nefrología, Instituto Nacional de Cardiología Dr. Ignacio Chávez, México D.F
2 Servicio de Patología, Instituto Nacional de Cardiología Dr. Ignacio Chávez, México D.F
Este artículo ha recibido
Información del artículo
Resumen

Presentamos el caso de una mujer de 30 años, mexicana, que luego de permanecer sin datos de actividad lúpica renal por 13 años, desde su diagnóstico, sin inmunosupresión crónica, experimenta un deterioro general por un estado autoinmune severo desencadenado tras un embarazo a término sin complicaciones, presentando, incluso, hemorragia alveolar difusa en 2 ocasiones, durante 12 meses, en el contexto de anticuerpos anti citoplasma de neutrófilos ANCA (+), volviendo su manejo difícil desde el punto de vista terapéutico con esquemas de inmunosupresión triple y cuádruple. Durante su evolución ha desarrollado microangiopatía cerebral y laringitis, por lo que se plantea la posibilidad de un síndrome de sobreposición lupus eritematoso sistémico – vasculitispauciinmune, una entidad no bien descrita en la literatura, cuyo diagnóstico está plagado de dificultades al no existir criterios definidos, ni la verdadera implicación de los ANCA en un paciente con lupus.

Palabras clave:
Lupus
nefritislúpica
vasculitis
hemorragia pulmonar
ANCA
síndrome de sobreposición
Summary

We report the case of a woman of 30 years, Mexican, who after spending without renal lupus activity data for 13 years after diagnosis, without chronic immunosuppression, experienced a general decline for severe autoimmune condition triggered after an uncomplicated term pregnancy presenting even diffuse alveolar hemorrhage in 2 occasions within 12 months, in the context of Anti neutrophil cytoplasmic ANCA (+), becoming its handling difficult from the point of view of therapeutic immunosuppression regimens triple and quadruple. During its evolution has developed cerebral microangiopathy and laryngitis which raises the possibility of an overlap syndrome lupuserythematosus – ANCA associated vasculitis, an entity not well described in the literature, whose diagnosis is fraught with difficulties in the absence of defined criteria or true ANCA involvement in a patient with lupus.

Key words:
Lupus nephritis
vasculitis
pulmonary hemorrhage
ANCA
overlap syndrome
El Texto completo está disponible en PDF
Referencias
[1.]
M.R. Zamora, M.L. Warner, R. Tuder, M.I. Schwarz.
Diffuse alveolar hemorrhage and systemic lupus erythematosus: clinical presentation, histology, survival, and outcome.
Medicine, 76 (1997), pp. 192-202
[2.]
A.S. Santos-Ocampo, B.F. Mandell, B.J. Fessler.
Alveolar hemorrhage in systemic lupus erythematosus: presentation and management.
Chest, 118 (2000), pp. 1083-1090
[3.]
M.Y. Chang, J.T. Fang, Y.C. Chen, C.C. Huang.
Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan.
Ren Fail, 24 (2002), pp. 791-802
[4.]
H. Badsha, C.L. Teh, K.O. Kong, T.Y. Lian, H.H. Chng.
Pulmonary hemorrhage in systemic lupus erythematosus.
Semin Arthritis Rheum, 33 (2004), pp. 414-421
[5.]
J.L. Myers, A.A. Katzenstein.
Microangiitis in lupus-induced pulmonary hemorrhage.
Am J ClinPathol, 85 (1986), pp. 552-556
[6.]
Ulrich Specks. Diffuse alveolar hemorrhage syndromes.
Rheumatol, 13 (2001), pp. 12-17
[7.]
N. De Prost, A. Parrot, E. Cuquemelle, C. Picard, M. Antoine, J. Fleury, et al.
Diffuse alveolar hemorrhage in immunocompetent patients: etiologies and prognosis revisited.
Respir Med, 106 (2012), pp. 1021-1032
[8.]
H.J. Chin, C. Ahn, C.S. Lim, H.K. Chung, J.G. Lee, Y.W. Song, et al.
Clinicalimplications of anti-neutrophil cytoplasmic antibodytest in lupus nephritis.
Am J Nephrol, 20 (2000), pp. 57-63
[9.]
V.D. Pradhan, S.S. Badakere, BichileLS, A.F. Almeida.
Anti-neutrophil cytoplasmicantibodies (ANCA) in systemic lupuserythematosus: prevalence, clinical associations and correlation with other autoantibodies.
J Assoc Physicians India, 52 (2004), pp. 533-537
[10.]
H.F. Pan, X.H. Fang, G.C. Wu, W.X. Li, X.F. Zhao, X.P. Li, et al.
Anti-neutrophil cytoplasmicantibodies in new-onset systemic lupuserythematosus and lupus nephritis.
Inflammation, 31 (2008), pp. 260-265
[11.]
P.E. Spronk, H. Bootsma, G. Horst, M.G. Huitema, P.C. Limburg, J.W. Tervaert, et al.
Anti-neutrophil cytoplasmic antibodies in systemic lupus erythematosus.
Br J Rheumatol, 35 (1996), pp. 625-631
[12.]
P.A. Merkel, R.P. Polisson, Y. Chang, S.J. Skates, J.L. Niles.
Prevalence of anti-neutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.
Ann Intern Med, 126 (1997), pp. 866-873
[13.]
M. Ramos-Casals, N. Nardi, M. Lagrutta, P. Brito-Zerón, A. Bové, G. Delgado, et al.
Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients.
[14.]
C. Drenkard, A.R. Villa, E. Reyes, M. Abello, D. Alarcón.
Vasculitis in systemic lupuserythematosus.
Lupus, 6 (1997), pp. 235-242
[15.]
EwertBH, R.J. Falk.
The pathogenetic role of anti-neutrophil cytoplasmic autoantibodies.
Am J Kidney Dis, 18 (1991), pp. 188-195
[16.]
J. Kluz, W. Kopec, U. Jakobsche-Policht, R. Adamiec.
Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
IntAngiol, 28 (2009), pp. 192-201
[17.]
M. Elshal, A. Abdelaziz, A. Abbas, K. Mahmoud, H. Fathy, S. El Mongy, et al.
Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair.
Nephrol Dial Transplant, 24 (2009), pp. 1495-1499
[18.]
Shoichi Ozaki.
ANCA – associated vasculitis: Diagnostic and Therapeutic Strategy.
Allergol Int, 56 (2007), pp. 87-96
[19.]
Floege, Johnson.
Renal and Systemic Vasculitis.
Comprehensive Clinical Nephrology, pp. 292-307
[20.]
Angelo L. Gaffo.
Diagnostic Approach to ANCA – associated Vasculitides.
Rheum Dis Clin N Am, 36 (2010), pp. 491-506
[21.]
B. Hervier, M. Hamidou, J. Haroche, C. Durant, A. Mathian, Z. Amoura.
Systemic lupuserythematosusassociated with ANCA-associated vasculitis: an overlapping syndrome?.
Rheumatol Int, 32 (2012), pp. 3285-3290
[22.]
Y. Kawachi, H. Nukaga, M. Hoshino, M. Iwata, F. Otsuka.
ANCA-associated vasculitis and lupus-like syndrome caused by methimazole.
ClinExpDermatol, 20 (1995), pp. 345-347
[23.]
M. Galeazzi, G. Morozzi, G.D. Sebastiani, F. Bellisai, R. Marcolongo, R. Cervera, et al.
Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European Concerted Action on the Immunogenetics of SLE.
ClinExpRheumatol, 16 (1998), pp. 541-546
[24.]
K. Molnár, L. Kovács, M. Kiss, S. Husz, A. Dobozy, G. Pokorny.
Anti-neutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.
ClinExpDermatol, 27 (2002), pp. 59-61
[25.]
F. Yu, Y. Tan, G. Liu, S.X. Wang, W.Z. Zou, M.H. Zhao.
Clinicopathological characteristics and outcomes of patients with crescenticlupus nephritis.
Kidney Int, 76 (2009), pp. 307-317
[26.]
L. Thurner, PreussKD, N. Fadle, E. Regitz, P. Klemm, M. Zaks, et al.
Progranulinantibodies in autoimmune diseases.
J autoimmun, (2012),
[27.]
N. Tsuchiya.
Genetics of ANCA-associatedvasculitis in Japan: a role for HLA-DRB1*09:01 haplotype.
ClinExpNephrol, (2012 nov), pp. 23
Copyright © 2013. Asociación Colombiana de Reumatología
Descargar PDF
Opciones de artículo